DDP
Showing 1 - 25 of 380
Implementing Dyadic Developmental Psychotherapy - Evaluation
Enrolling by invitation
- Psychiatric Problem
- +4 more
- Dyadic Developmental Psychotherapy
-
Skien, Vestfold Og Telemark, NorwayTelemark Hospital Trust
Apr 22, 2022
Suicidal Ideation Trial in Syracuse (Dynamic Deconstructive Psychotherapy (DDP), Brief Intervention and Contact (BIC))
Not yet recruiting
- Suicidal Ideation
- Dynamic Deconstructive Psychotherapy (DDP)
- Brief Intervention and Contact (BIC)
-
Syracuse, New YorkSUNY Upstate Medical University, Psychiatry High Risk Program (P
Aug 11, 2023
Delirium Trial (Emergency Department Delirium Screening and Detection Program (ED-DDP))
Not yet recruiting
- Delirium
- Emergency Department Delirium Screening and Detection Program (ED-DDP)
- (no location specified)
Jan 6, 2023
Delirium Trial (ED Delirium Screening and Detection Program (ED-DDP))
Not yet recruiting
- Delirium
- ED Delirium Screening and Detection Program (ED-DDP)
- (no location specified)
Jan 6, 2023
Stimulant Use Trial in Chicago (Methamphetamine, oral tablet)
Recruiting
- Stimulant Use
- Methamphetamine
- placebo oral tablet
-
Chicago, IllinoisUniversity of Chicago
May 19, 2022
Diabetes, Prostatic Hyperplasia Trial in Cairo (International prostate symptom score, Assessment of prostate volume, Pittsburgh
Completed
- Diabetes Mellitus
- Prostatic Hyperplasia
- International prostate symptom score
- +3 more
-
Cairo, Egypt
- +1 more
Nov 19, 2023
Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)
Not yet recruiting
- Esophagus Cancer
- Cadonilimab
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Nov 20, 2023
Cancer of Head and Neck, Head Neck Cancer, Tumors, Head and Neck Trial in Boston, Saint Louis, New York (biological, procedure,
Active, not recruiting
- Cancer of Head and Neck
- +5 more
- MK-3475 (neoadjuvant)
- +6 more
-
Boston, Massachusetts
- +2 more
Dec 9, 2022
Patient Discharge Trial in Torino (On Demand Discharge Planning (DDP), Routine Discharge Planning (RDP))
Completed
- Patient Discharge
- On Demand Discharge Planning (DDP)
- Routine Discharge Planning (RDP)
-
Torino, ItalyAOU Città della Salute
Mar 15, 2022
Uterine Cervical Tumors Trial in Nanning (Tislelizumab, DDP synchronous with radiotherapy)
Recruiting
- Uterine Cervical Neoplasms
- Tislelizumab
- DDP synchronous with radiotherapy
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Oct 19, 2022
Nasopharyngeal Carcinoma Trial in Beijing (intensity-modulated radiotherapy (IMRT) with reduced-volume, Cisplatin (DDP))
Not yet recruiting
- Nasopharyngeal Carcinoma
- intensity-modulated radiotherapy (IMRT) with reduced-volume
- Cisplatin (DDP)
-
Beijing, ChinaCancer hospital, Chinese Academy of Medical Sciences
Nov 22, 2021
Stroke Trial in Charleston (Duck Duck Punch, Aerobic exercise, Lower extremity stretching)
Recruiting
- Stroke
- Duck Duck Punch
- +2 more
-
Charleston, South CarolinaRalph H. Johnson VA Medical Center, Charleston, SC
Jun 15, 2022
Cervical Cancer Trial in Nanning (tislelizumab, concurrent chemoradiotherapy)
Not yet recruiting
- Cervical Cancer
- tislelizumab
- concurrent chemoradiotherapy
-
Nanning, Guangxi, ChinaFirst Affiliated Hospital of Guangxi Medical University
Aug 22, 2022
Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)
Recruiting
- Squamous Cell Esophageal Carcinoma
- +2 more
- Sintilimab
- +4 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 11, 2022
Metastatic Breast Cancer Trial in Shanghai (Vinorelbine, DDP)
Recruiting
- Metastatic Breast Cancer
- Vinorelbine
- DDP
-
Shanghai, ChinaFudan University Cancer Hospital
Apr 19, 2022
Esophageal Squamous Cell Carcinoma Trial in China (Anlotinib Hydrochloride, Paclitaxel, cisplatin)
Active, not recruiting
- Esophageal Squamous Cell Carcinoma
- Anlotinib Hydrochloride, Paclitaxel, cisplatin
-
Anyang, Henan, China
- +5 more
Aug 23, 2021
Pancreatic Tumor Trial in Shanghai (intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel)
Recruiting
- Pancreatic Neoplasm
- intraperitoneal (IP) Cisplatin combined with intravenous gemcitabine + nab-paclitaxel
-
Shanghai, Shanghai, China
- +1 more
Feb 2, 2022
Head Neck Cancer Trial in Columbus (drug, radiation, procedure)
Terminated
- Head and Neck Cancer
- Cisplatin
- +3 more
-
Columbus, OhioOhio State University Medical Center
Oct 29, 2021
Oropharynx Cancer Trial in Pittsburgh (procedure, other, radiation, drug)
Recruiting
- Oropharynx Cancer
- therapeutic conventional surgery
- +5 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 4, 2022
Medulloblastoma Trial in Memphis (procedure, drug, radiation)
Recruiting
- Medulloblastoma
- Surgical resection
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Sep 16, 2022
Nasopharyngeal Carcinoma Trial in China (Camrelizumab, Gemcitabine, Induction Cisplatin)
Not yet recruiting
- Nasopharyngeal Carcinoma
- Camrelizumab
- +4 more
-
Guilin, Guangxi, China
- +4 more
Oct 15, 2021
Nasopharyngeal Carcinoma Trial in Nanning (endostar, DDP, IMRT)
Completed
- Nasopharyngeal Carcinoma
- endostar
- +2 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Jan 30, 2022
Gestational Trophoblastic Tumors Trial in Hangzhou (Etoposide, actinomycin D, methotrexate)
Recruiting
- Gestational Trophoblastic Neoplasms
- Etoposide
- +7 more
-
Hangzhou, Zhejiang, ChinaWeiguo Lv
Jun 2, 2022
Hepatitis C Trial in La Laguna (Screening HCV. HR-HOSPITAL, Screening HCV. HR-DDP, Screening HCV. GP-HOSPITAL)
Recruiting
- Hepatitis C
- Screening HCV. HR-HOSPITAL
- +3 more
-
La Laguna, Santa Cruz De Tenerife, SpainComplejo Hospitalario Universitario de Canarias
Feb 12, 2022
Recurrent or Metastatic Cervical Cancer Trial in Changsha, Hangzhou (AK104, Bevacizumab, Paclitaxel)
Active, not recruiting
- Recurrent or Metastatic Cervical Cancer
- AK104
- +3 more
-
Changsha, Hunan, China
- +1 more
Mar 28, 2022